414 related articles for article (PubMed ID: 34109184)
1. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
He T; Huang L; Li J; Wang P; Zhang Z
Front Med (Lausanne); 2021; 8():587496. PubMed ID: 34109184
[No Abstract] [Full Text] [Related]
2. Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms.
Zhang Z; Li J; He T; Ding J
Front Oncol; 2020; 10():330. PubMed ID: 32296631
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis reveals immune prognostic markers for overall survival of colorectal cancer patients: a novel machine learning survival predictive system.
Zhang Z; Huang L; Li J; Wang P
BMC Bioinformatics; 2022 Apr; 23(1):124. PubMed ID: 35395711
[TBL] [Abstract][Full Text] [Related]
4. Immune gene prognostic signature for disease free survival of gastric cancer: Translational research of an artificial intelligence survival predictive system.
Zhang Z; He T; Huang L; Li J; Wang P
Comput Struct Biotechnol J; 2021; 19():2329-2346. PubMed ID: 34025929
[TBL] [Abstract][Full Text] [Related]
5. Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma.
Liang J; He T; Li H; Guo X; Zhang Z
J Transl Med; 2022 Jun; 20(1):293. PubMed ID: 35765031
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma.
He T; Li J; Wang P; Zhang Z
Comput Struct Biotechnol J; 2022; 20():2352-2359. PubMed ID: 35615023
[TBL] [Abstract][Full Text] [Related]
7. Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools.
Lin J; Lu S; Jiang Z; Hu C; Zhang Z
PeerJ; 2021; 9():e11412. PubMed ID: 34012732
[TBL] [Abstract][Full Text] [Related]
8. Development of a multi-gene-based immune prognostic signature in ovarian Cancer.
Cao T; Shen H
J Ovarian Res; 2021 Jan; 14(1):20. PubMed ID: 33509250
[TBL] [Abstract][Full Text] [Related]
9. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer.
Wang Y; Li BX; Li X
Front Oncol; 2021; 11():783666. PubMed ID: 35047401
[TBL] [Abstract][Full Text] [Related]
11. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma.
Zhang Z; Li J; He T; Ouyang Y; Huang Y; Liu Q; Wang P; Ding J
Cancer Sci; 2019 Sep; 110(9):2905-2923. PubMed ID: 31335995
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
13. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
14. A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.
Pan X; Bi F
Front Genet; 2021; 12():694009. PubMed ID: 34367253
[TBL] [Abstract][Full Text] [Related]
15. An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma.
Geng T; Zheng M; Wang Y; Reseland JE; Samara A
Front Mol Biosci; 2023; 10():1200354. PubMed ID: 37388244
[No Abstract] [Full Text] [Related]
16. Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer.
Liu J; Xu F; Cheng W; Gao L
Exp Cell Res; 2020 Oct; 395(2):112235. PubMed ID: 32805252
[TBL] [Abstract][Full Text] [Related]
17. Two predictive precision medicine tools for hepatocellular carcinoma.
Zhang Z; Li J; He T; Ouyang Y; Huang Y; Liu Q; Wang P; Ding J
Cancer Cell Int; 2019; 19():290. PubMed ID: 31754347
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a transcription factors-based prognostic signature for ovarian cancer.
Cheng Q; Li L; Yu M
J Ovarian Res; 2022 Feb; 15(1):29. PubMed ID: 35227285
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
20. Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer.
He C; Huang F; Zhang K; Wei J; Hu K; Liang M
J Ovarian Res; 2021 Feb; 14(1):27. PubMed ID: 33550985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
